openPR Logo
Press release

Alzheimer's Disease Therapeutics And Diagnostic Market Analysis & Technological Innovation by Top Key Players: Baxter, AbbVie, Cognoptix, AXON Neuroscience SE, Biogen, DiaGenic ASA, Sun Pharmaceutical Industries Ltd., Amarantus BioScience Holdings, Inc.,

03-18-2020 05:28 PM CET | Health & Medicine

Press release from: Market Study Report LLC

Alzheimer's Disease Therapeutics And Diagnostic Market

Market Study Report recently introduced new title on "2020-2027 Global Alzheimer's Disease Therapeutics And Diagnostic Market Report" that provides an in-depth overview of industry and competitive landscape, covering multiple market segments and elaborates market outlook and status to 2025.

The Alzheimer's disease therapeutics and diagnostics market is expected to progress at a CAGR of 7.78% during the years 2019-2027. The market is driven by the rise in the number of Alzheimer's cases and the growing demand for personalized drugs and affordable diagnostics tests. However, the stringent regulations for the development of drugs and clinical trials are hindering the growth of the Alzheimer's disease therapeutics and diagnostics market globally.

Request Sample Of this premium Report: https://www.marketstudyreport.com/request-a-sample/2515930/?utm_source=Openpr.com&utm_medium=TS

The high cost of therapies used for the treatment of Alzheimer's disease also contributes to the same. A key challenge in the growth of the global Alzheimer's disease therapeutics and diagnostics market is the shortage of skilled medical practitioners across the developing countries. Also, the lack of awareness regarding new therapies that are used for the treatment of the Alzheimer's disease acts as a significant growth challenge for the global Alzheimer's disease therapeutics and diagnostics market over the forecast period.

Regional Outlook
The Alzheimer's disease therapeutics and diagnostics market in Asia-Pacific is the fastest-growing market globally. The primary driver of the Alzheimer's disease therapeutics and diagnostics market in China is the burgeoning rise in the population of the country, which is thereby increasing the aging population. This aging population is vulnerable to diseases like dementia, thus causing a rise in its prevalence across the country, mainly in the semi-urban and rural provinces. According to the Ministry of Health, China is one of the leading countries in terms of the number of individuals affected by dementia, which accounts for around 20% of the dementia cases globally.

Europe, Asia Pacific and North America and rest of the world are the regional segments of the global Alzheimer's disease therapeutics and diagnostics market. Presently, it is the Asia Pacific region that is holding the reign globally. With the government investment in the R&D for drugs and diagnostic test, which is further supported by the increasing population and the large proportion of people aged above 65 years in the regions, the demand for personalized drugs is expected to witness a boom for the Alzheimer's disease therapeutics and diagnostics market in this region.

Prominent Players in the market
Some of the major players that are engaged in the Alzheimer's disease therapeutics and diagnostics market include
o Baxter
o AbbVie
o Cognoptix
o AXON Neuroscience SE
o Biogen DiaGenic ASA
o Sun Pharmaceutical Industries Ltd.
o Amarantus BioScience Holdings, Inc.
o Merck
o Piramal Enterprises Ltd.
o Johnson & Johnson
o Roche
o Siemens Healthineers AG
o GE Healthcare.

DiaGenic ASA is a life sciences company engaged in the development and delivery of patient-friendly tests to diagnose of devastating diseases at early stages. The company is currently focused on the development of IVD biomarker products and is also active in identifying gene expression signatures in blood in the field of Alzheimer's disease. MCItect and New ADtect are some of the products that are a part of the company's product portfolio. New ADtect is used for detecting mild to moderate AD.

Request a discount on standard prices of this premium report at: https://www.marketstudyreport.com/check-for-discount/2515930/?utm_source=Openpr.com&utm_medium=TS

Table Of Content
1. Global Alzheimer's Disease Therapeutics And Diagnostic Market - Summary
2. Industry Outlook
3. Alzheimer's Disease Therapeutics And Diagnostics Market Outlook - By Therapeutics And Diagnostics
3.1. Therapeutics
3.2. Diagnostic Type
4. Alzheimer's Disease Therapeutics And Diagnostics Market - Regional Outlook
4.1. North America
4.2. Europe
4.3. Asia-Pacific
4.4. Latin America
4.5. Middle East And Africa
5. Company Profiles
6. Research Methodology & Scope
6.1. Research Scope & Deliverables
6.2. Sources Of Data
6.3. Research Methodology

Related Report:
Global Injectable Drug Delivery Market 2019-2027

According to an analysis by a Market Research, the global injectable drug delivery market is predicted to grow at a CAGR of 8.67% during the forecasting period 2019-2027. The increasing geriatric population, the advancement in the technologies and the growing occurrences of auto-immune diseases are some of the key factors driving the global market of the injectable drug delivery.

https://www.marketstudyreport.com/reports/global-injectable-drug-delivery-market-2019-2027?utm_source=Openpr.com&utm_medium=TS

Contact Us:
Market Study Report LLC
4 North Main Street,
Selbyville, Delaware 19975
USA
Phone: 1-302-273-0910
US Toll Free: 1-866-764-2150
Email: sales@marketstudyreport.com
Website: https://www.marketstudyreport.com
Blog: https://www.marketstudyreport.com/blog

About Us:
Marketstudyreport.com allows you to manage and control all corporate research purchases to consolidate billing and vendor management. You can eliminate duplicate purchases and customize your content and license management.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Alzheimer's Disease Therapeutics And Diagnostic Market Analysis & Technological Innovation by Top Key Players: Baxter, AbbVie, Cognoptix, AXON Neuroscience SE, Biogen, DiaGenic ASA, Sun Pharmaceutical Industries Ltd., Amarantus BioScience Holdings, Inc., here

News-ID: 1974075 • Views:

More Releases from Market Study Report LLC

COVID-19 Detection Kits Market Size o witness substantial growth during 2020-202 …
The research report on ‘COVID-19 Detection Kits market’ scrutinizes the current industry scenario to predict market size, market share, and projects valuation for different segmentations of the industry over 2020-2026. It provides business intelligence regarding various factors driving the industry growth in consort with discussing the challenges faced by the industry, and the approaches followed by market players to counter their impact. COVID-19 Detection Kits Market size to grow with
What's driving the Small Satellite Market trends? Raytheon, Lockheed Martin, Northrop Gruman, Dynetics, Surrey Satellite Technology, Axelspace, Sierra Nevada, Clyde Space, Planet Labs, Dauria Aerospace, CASC
What's driving the Small Satellite Market trends? Raytheon, Lockheed Martin, Nor …
Market Study Report LLC adds new research on Small Satellite market, which is a detailed analysis of this business space inclusive of the trends, competitive landscape, and the market size. Encompassing one or more parameters among product analysis, application potential, and the regional growth landscape, Small Satellite market also includes an in-depth study of the industry competitive scenario. The global Small Satellite market is valued at 1340 million US$ in 2018
What's driving the Antibiotics Market trends? Sanofi, Novartis AG, Pfizer Inc., Bayer AG, Abbott, Eli Lilly and Company. Johnson & Johnson Services, Inc., GlaxoSmithKline plc., Bristol-Myers Squibb Company, Astellas Pharma Inc.,
What's driving the Antibiotics Market trends? Sanofi, Novartis AG, Pfizer Inc., …
Market Study Report LLC has added a new report on Antibiotics market that provides a comprehensive review of this industry with respect to the driving forces influencing the market size. Comprising the current and future trends defining the dynamics of this industry vertical, this report also incorporates the regional landscape of Antibiotics market in tandem with its competitive terrain. The antibiotics was valued at US$ 43,348.38 million in 2019 and is
What's driving the Electrical House (E-House) Market trends? Schneider Electric, ABB, Siemens, Eaton and General Electric
What's driving the Electrical House (E-House) Market trends? Schneider Electric, …
Market Study Report LLC has added a new report on Electrical House (E-House) market that provides a comprehensive review of this industry with respect to the driving forces influencing the market size. Comprising the current and future trends defining the dynamics of this industry vertical, this report also incorporates the regional landscape of Electrical House (E-House) market in tandem with its competitive terrain. Electrical House (E-House), also called Power House, is

All 5 Releases


More Releases for Alzheimer

Dementia - Alzheimer Disease Market: A Comprehensive Analysis 2030
Dementia and Alzheimer's disease represent significant challenges within the global healthcare sector. These neurological disorders, characterized by progressive cognitive decline, have seen increasing prevalence due to aging populations worldwide. This growing burden has spurred interest in the Dementia - Alzheimer's disease market, encompassing diagnostic tools, treatments, caregiving solutions, and related healthcare services. This article provides an overview of the market, its scope, current trends, and factors driving its expansion. Data Bridge
Alzheimer Disease Treatment Market | Allergan, Amgen, Daiichi Sankyo, Eisai
The global alzheimer disease treatment market report is a comprehensive report that provides a detailed analysis of the current status and future trends of the alzheimer disease treatment market worldwide. This report provides valuable information to industry stakeholders by offering an in-depth perspective on market dynamics, competitive landscape, growth opportunities, and key challenges faced by industry participants. From the perspective of market dynamics, this report explores the factors driving the growth
United States Alzheimer Drugs Market Insights Deep Analysis 2023-2031
Cognate Life Sciences introduces a report on "United States Alzheimer Drugs Market 2023" with Market Insights Reports, Introduces systematic details in terms of market valuation, market size, revenue estimation, and geographical spectrum of the business vertical. The study also talks about crucial pockets of the industry such as products or services offered, downstream fields, end using customers, historic data figures regarding revenue and sales, market context and more. It conjointly
Global Alzheimer Market, Global Alzheimer Industry, Covid-19 Impact Global Alzhe …
Alzheimer's is a progressive disease that leads to the death of brain cells, resulting in memory loss, behavioral issues, and disruption the thought processes. The Alzheimer disease is considered fatal. Age and heredity are the two main risk factors for developing Alzheimer's disease. Several other preventable risk factors have been associated to the development of this disease, including diet, environment, and overall general health. A combination of risk factors is
US Alzheimer Drug Pipeline Analysis
In US, the Alzheimer's disease is the 6th leading cause of death overall and among those aged 65 and above, it is the 5th leading cause of death. While the deaths from major diseases, like heart disease have decreased, the death due to Alzheimer's have increased by more than 60% between 2000 and 2012. The total number of patients having Alzheimer’s disease was 5.4 million in 2012. Out of this,
Global Alzheimer Market Report: 2015 Edition | Now Available at Researchmoz.us
Researchmoz added Most up-to-date research on "Global Alzheimer Market Report: 2015 Edition" to its huge collection of research reports. Alzheimer’s disease is defined as an advanced neurological disorder that increasingly deprives patients of their memory and ability to carry out daily activities. As it grows in a human brain, individuals are likely to practice difficulties in linguistic, agility and insight along with negative changes in the character and performance such as